Ergomed Group
Ergomed Group provides specialist services to the pharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information.
Locations
- Africa
- APAC
- Australia
- Europe
- North America
- South America
Therapeutic Areas
- Cardiovascular
- Dermatology
- Endocrinology
- Hematology
- Hepatology
- Infectious Diseases
- Metabolic Diseases
- Nephrology
- Neurology
- Oncology
- Rare Disease
- Respiratory
Founded in 1997, Ergomed is dedicated to providing global specialized services in the pharmaceutical and biotech industry. Today, Ergomed supports pharmaceutical companies with services spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Recognized internationally for its expertise in both rare disease and oncology drug development, Ergomed offers a full range of quality clinical research and clinical trial management services along with an industry-leading suite of specialized pharmacovigilance solutions. By providing this full-service offering, Ergomed enables emerging and established life sciences companies to meet their regulatory obligations and maximize their drug development success and their product value.